Clinical Trials

Showing trials with last updates posted in 2023.

NCT04401319 | UNKNOWN | NA
90 participants

rTMS and EEG in DOC Patients

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-12
Start Date:
2024-07-31
Completion:
2024-11-30
Conditions
  • Disorder of Consciousness
Interventions
  • DEVICE
No Results Yet
NCT03734601 | COMPLETED | PHASE2
22 participants

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-12
Start Date:
2018-11-05
Completion:
2019-12-26
Conditions
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorder
  • Chronic Lymphocytic Leukemia
  • B-cell Lymphoma
  • T-cell Lymphoma
  • Non Hodgkin Lymphoma
  • Hodgkin Lymphoma
  • Chronic Myelomonocytic Leukemia
Interventions
  • RADIATION
  • DRUG
NCT03638375 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2
34 participants

TIL and Anti-PD1 in Metastatic Melanoma

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-12
Start Date:
2018-07-31
Completion:
2025-11-29
Conditions
  • Toxicity, Drug
  • Adverse Drug Event
  • Effects of Immunotherapy
Interventions
  • DRUG
No Results Yet
NCT03525392 | TERMINATED | PHASE1
14 participants

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Study Type:
INTERVENTIONAL
Last Updated:
2023-12-12
Start Date:
2018-05-03
Completion:
2020-04-03
Conditions
  • Pancreatic Ductal Adenocarcinoma
  • Colorectal Cancer
  • Gastric Cancer
  • Squamous Cell Carcinoma of the Head and Neck
  • Bone Cancer
  • Advanced Cancer
  • Recurrent Disease
  • Metastatic Tumours
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page